Skip to main content
OpenTrials
Completed

NCT Number: NCT03052166

Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Breast Imaging

Brief Summary: The QT Ultrasound system is an automated scanner which transmits pulsed ultrasound plane waves through the breast, as well as collects reflected ultrasound output. As the patient lays prone on a table, the breast is submerged in a warm water bath. The transmitter and receiver assembly moves around the suspended breast to record data for successive sub-volumes of targeted tissue. More than 2000 elements in the curvilinear transducer's array encircle the breast to gather data from the tissue structures of the breast, from nipple to chest wall. Information gathered from this automated QT scan encompasses the entire breast which is currently not commercially available using any other ultrasound technology.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Memorial Care Long Beach, Long Beach, California, United States

Loading trial locations.

About this study

This is a prospective, multicenter, multi-arm case collection study, with IRB approval. The study will follow an adaptive design with an initially planned total enrollment of approximately 600 cases to include both benign and malignant cases, representative of all tissue densities.

The images and clinical data accrued in this prospective case collection will be used for creation of a database to facilitate future reader's studies, publications, building teaching files, and future marketing for QT Ultrasound.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

All Subjects

  • Female
  • Age 18 or older
  • Willing to receive a QT Ultrasound Breast Scan
  • Willing and able to provide written Informed Consent prior to any research-related procedure(s)

Cohort A and B Subjects that do not meet these Inclusion Criteria will be evaluated for Inclusion in Cohort C

  • Eligible for routine screening mammography as per ACR guidelines
  • Willing and able to submit or complete at the clinical site a Digital Mammography with Digital Breast Tomosynthesis exam (to include Craniocaudal (CC) and Mediolateral Oblique (MLO) views - for one or both breasts, within 3 months, before or after, their QT scan.

Cohort C

  • Willing and able to submit available breast imaging - for one or both breasts, before or after, their QT scan.

Exclusion criteria

All Subjects

  • Pregnancy
  • Currently breastfeeding
  • Allergies to device materials
  • Physical inability to tolerate the procedure on the scanner, i.e. inability to lie prone and still for up to 30 minutes at a time
  • Open wounds, sores or skin rash present on the breast(s) or nipple discharge from the scanned breast
  • Breasts too large for scanner, i.e. inability to successfully "fit" breast after the subject is placed on scanner
  • Body weight greater than 400 lbs. (180 kg)
  • Has a concurrent disease or condition which in the judgment of the Principal Investigator disqualifies the subject, from participating in the study
  • Magnetic material in the chest which in the judgement of the Principal Investigator would interfere with or be impacted by the magnets within the study device.

Cohort A and B Subjects that meet any of these conditions below will not be eligible for Cohort A or B and will be evaluated for eligibility in Cohort C.

  • History of breast cancer in the past 12 months.
  • Most recent screening mammography exam was completed more than 3 months but less than 11 months prior.
  • History of breast surgeries or interventional breast procedures in the past 12 months, except for Fine Needle Aspiration(s) or Cyst Aspiration(s)

Treatment and study plan

QT Ultrasound scan

Device

QT Ultrasound scan

Primary outcomes

  1. Comparison of QT Ultrasound to DM-DBT

    Time frame: 12 months

    Non-inferiority evaluation of sensitivity, specificity, positive predictive value and non-cancer recall rate.

Sponsors and collaborators

Lead sponsor

QT Ultrasound LLC

Industry

Registry information

Official study title

A Prospective Multi-center Case Collection Study of Breast Imaging Examinations From Women to Evaluate the Non-inferiority of QT Ultrasound Compared to Digital Mammography-Digital Breast Tomography (DM-DBT)

Acronym: ACCRUE

Important dates

Study start
2017
Primary completion
2019
Study completion
2020
First posted
Feb 14, 2017
Registry last updated
Mar 18, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.